Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25577272 | 0.98 | KDM4E (0.35) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL25579122 | 0.96 | PDK2 (0.33) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24856356 | 0.96 | PDK2 (0.33) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL25577132 | 0.96 | KDM4E (0.34) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL25579134 | 0.95 | PDK2 (0.32) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL25579121 | 0.94 | PDK2 (0.34) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL25577275 | 0.94 | KDM4E (0.35) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24856496 | 0.94 | KDM4E (0.34) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24856502 | 0.94 | PDK2 (0.34) | PDK2 | |
| SCHEMBL25580341 | 0.93 | KDM4E (0.32) | KDM4EMEN1LMNAMAPTOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| WO-2023273997-A1 | ORGANIC COMPOUND AND APPLICATION THEREOF | 北京鼎材科技有限公司 | 2023-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | ESR1, L1CAM, ESR2 | KDM4E 2752/4885MEN1 101/4885LMNA 758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.